Skip to content

Opko Health OPK IE — Revenue

Other geography segments

US
$116.21M
CL
$14.53M
ES
$6.44M
MX
$6.23M
IL
$73K

Similar metrics at other companies

Alkermes logo
ALKSIE — Revenue
$188.5K-41.7%
WisdomTree logo
WTIE — Revenue (Gross)
$13.94M+132%
Argan logo
AGXIE — Revenue
$24.14M+144%
Bel Fuse logo
BELFBIN — Revenue
$2.21M-16.8%
Herbalife logo
HLFIN — Revenue
$275.4M+31.6%
HRO
HROWIHEEZO — Revenue
$1.85M-64.6%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's ie — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's IE — revenue?
Opko Health (OPK) reported IE — revenue of $9.68M in Q1 2026.
How has Opko Health's IE — revenue changed year-over-year?
Opko Health's IE — revenue increased by 76.6% year-over-year, from $5.48M to $9.68M.
What is the long-term trend for Opko Health's IE — revenue?
Over 4 years (2021 to 2025), Opko Health's IE — revenue has grown at a 11.9% compound annual growth rate (CAGR), from $32.81M to $51.4M.
What does IE — revenue mean?
This metric measures the total gross income generated from the sale of goods and services within the Ireland segment, net of any sales-related taxes. It serves as a primary indicator of the segment's commercial performance and market demand for its pharmaceutical or diagnostic offerings. Tracking this revenue stream helps investors evaluate the segment's contribution to the company's overall top-line growth and operational scale.